Table 1.
BRCA and USP15 meta-analysis with related factors such as sex, age, tumor typing, immune cell type, and data from TIMER.
Coef | HR | 95%CI_1 | 95XCI_U | p.value | Sig | |
---|---|---|---|---|---|---|
Age | 0.034 | 1.035 | 1.020 | 1.049 | 0.000 | ∗∗∗ |
Gendermale | -0.490 | 0.613 | 0.084 | 4.459 | 0.628 | |
raceBlack | -e.064 | 0.938 | 0.278 | 3.169 | 0.918 | |
raceWhite | -9.533 | 0.587 | 0.182 | 1.894 | 0.372 | |
stage2 | 8.580 | 1.786 | 0.990 | 3.222 | 0.054 | ∗ |
stage3 | 1.288 | 3.625 | 1.947 | 6.750 | 0.000 | ∗∗∗ |
stage4 | 2.688 | 14.700 | 6.677 | 32.367 | 0.000 | ∗∗∗ |
B_cell | -6.684 | 0.505 | 0.006 | 41.251 | 0.761 | |
CD8_Tcell | -1.733 | 0.177 | 0.015 | 2.144 | 0.174 | |
C04_Tcell | 0.197 | 1.218 | 0.030 | 50.000 | 0.917 | |
Macrophage | 2.439 | 11.466 | 0.849 | 154.784 | 0.066 | ∗ |
Neutrophil | 1.4S6 | 4.420 | 0.019 | 1017.417 | 0.592 | |
Dendritic | -8.494 | 0.610 | 0.081 | 4.597 | 0.632 | |
USP15 | 0.380 | 1.462 | 1.001 | 2.135 | 0.049 | ∗ |
Rsquare-0.085 (max possible = 7.96e − 01). Likelihood ratio test p = 3.62e-ll. Wald test p = 2.65e − 13. Score (logrank) test p > = 1.79e − 18.